Molecular Dx

Brigham and Women’s Hospital has launched the Preventive Genomics Clinic, a facility designed to provide comprehensive DNA sequencing, interpretation and reporting of disease-associated genes. The...

Researchers at Harvard Medical School have sequenced the genomes of a family in which multiple members had pancreatic cancer and found a mutation in a gene linked to the RAS signaling pathway that controls cell growth and death. Researchers argue that the into how RABL3 impacts the signaling pathway could lead to novel targeted therapy.

The Q-State Biosciences and 2bPrecise partnership aims to achieve improved diagnostic yields and patient outcomes by using clinical tools to match patients with precise therapies based on their health attributes and genetic profile.

Scientists have mapped the genetic diversity of microbes residing in the human gut and mouth.

GNA Biosolutions GmbH's new funding will spur the German company’s molecular diagnostics assay development.

GeneCentric Therapeutics said today it has entered the second phase of a diagnostic development collaboration with Jose Zevallos M.D., M.P.H., Chief of the Division...

Fecal transplants from long-term survivors of pancreatic cancer patients to newly diagnosed ones may one day save lives.

The American College of Medical Genetics and Genomics (ACMG) said today it will establish a program designed to develop new evidence-based guidelines in medical...

Liquid biopsy using urine is better than testing blood when it comes to accurately reflecting the genomic profile of bladder cancer tumors. That’s according...

Myriad Genetics said today it will pursue FDA authorization of its BRACAnalysis CDx test as a companion diagnostic for the AstraZeneca/Merck & Co. co-marketed...